Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - sodium thiosulfate -

Ireland - English - HPRA (Health Products Regulatory Authority)

aurum pharmaceutical limited - magnesium sulphate heptahydrate - solution for injection and concentrate for infusion - 50 percent weight/volume - electrolyte solutions; magnesium sulfate

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - sodium sulfate, quantity: 7.5 g; macrogol 3350, quantity: 100 g; potassium chloride, quantity: 1.015 g; ascorbic acid, quantity: 4.7 g; sodium ascorbate, quantity: 5.9 g; sodium chloride, quantity: 2.691 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

United States - English - NLM (National Library of Medicine)

hospira, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 10 mg in 1 ml - magnesium sulfate in 5% dextrose injection is indicated for: magnesium sulfate in 5% dextrose injection is contraindicated in patients: risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia [see warnings and precautions (5.1)] . the use of intravenous magnesium in pregnant women increases human milk magnesium concentrations only slightly and oral absorption of magnesium by the infant is poor. the

United States - English - NLM (National Library of Medicine)

padagis us llc - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 600 mg - potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. potassium chloride extended-release capsules are contraindicated in patients on amiloride or triamterene. risk summary there are no human data related to use of potassium chloride extended-release capsules during pregnancy and animal reproductive studies have not been conducted. potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm. the background risk for major birth defects and miscarriage in the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk su

United States - English - NLM (National Library of Medicine)

seroyal usa - sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750) - sodium sulfate 6 [hp_x] - uses for the temporary relief of symptoms associated with mild indigestion. uses for the temporary relief of symptoms associated with mild indigestion. directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under tongue. adults and adolescents (12 years and older): take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. children (under 12 years): take under the direction of your healthcare practitioner. uses for the temporary relief of symptoms associated with occasional anxiety overexertion mental fatigue indications for the temporary relief of symptoms associated with occasional anxiety overexertion mental fatigue directions tip bottle slightly allowing for tablets to fall into the cap. use cap to drop tablets into mouth and allow them to dissolve under the tongue. adults and adolescents (12 years and older): take 1 to 4 tablets, one to four times daily, or

United States - English - NLM (National Library of Medicine)

hospira, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 4 g in 50 ml - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

Ireland - English - HPRA (Health Products Regulatory Authority)

ethypharm - magnesium sulphate heptahydrate - solution for injection/infusion - 50 percent weight/volume - electrolyte solutions; magnesium sulfate

Philippines - English - FDA (Food And Drug Administration)

elanco philippines, inc; distributor: elanco philippines, inc - multivitamins , minerals , amino acid , nucleotides , yeast extract , evening primrose oil (vet.) - oral solution - formulation: each liter contains: retinyl propionate (vitamin a) 500,000, iu cholecalciferol (vitamin d3) 75,000, iu c-tocopheryl acetate (vitamin e) 10g, niacin 1.4g thiamine, (vitamin bi) 1.25 g, ascorbic acid (vitamin c) 1g, pyridoxine (vitamin b6) 625 mg, folic acid 625 mg, riboflavin (vitamin b2) 500 mg, vitamin k 350 mg, cyanocobalamin (vitamin b12) 5.3mg, biotin (vitamin h) 1.5 mg, zinc 3g, copper 2 g, manganese 1g, iodine (potassium lodide) 500 mg, cobalt 500 mg, magnesium sulfate heptahydrate 455 mg, selenium 125 mg, potassium chloride 82.43 g, sodium chloride 9.815 g, citric acid 3.28 g, methionine 1.5 g, lysine 1g, nucleotides 5g, yeast extract 1g, evening primrose oil 500 mg